Search details
1.
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Lab Invest
; 102(9): 957-965, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35488033
2.
Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status.
Blood Adv
; 2024 May 07.
Article
in English
| MEDLINE | ID: mdl-38713893
3.
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.
Exp Hematol Oncol
; 13(1): 34, 2024 Mar 25.
Article
in English
| MEDLINE | ID: mdl-38528594
4.
CD36 regulates substrates utilisation in brown adipose tissue of spontaneously hypertensive rats: In vitro study.
PLoS One
; 18(4): e0283276, 2023.
Article
in English
| MEDLINE | ID: mdl-37053180
5.
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.
Mol Cancer Ther
; 21(1): 89-99, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34728569
6.
CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement.
Leuk Lymphoma
; 62(4): 861-867, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33238780
Results
1 -
6
de 6
1
Next >
>>